IL2 and neoplasm: Ex vivo expansion of peripheral blood mononuclear cells with anti-CD3 antibodies, IL-2, and IFN-γ. Cytotoxity of those cells is based on contact of natural killer group 2 member D (NKG2D) with its ligand on tumor cells and the perforin-mediated pathways.